These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1692094)

  • 21. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1 beta. I. Tumor inhibition parallels lymphocyte-activating factor activity of interleukin 1 beta proteins.
    Pezzella KM; Neville ME; Huang JJ
    Cytokine; 1990 Sep; 2(5):357-62. PubMed ID: 2103334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.
    Schiffelers RM; Metselaar JM; Fens MH; Janssen AP; Molema G; Storm G
    Neoplasia; 2005 Feb; 7(2):118-27. PubMed ID: 15802017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
    Min HY; Doyle LV; Vitt CR; Zandonella CL; Stratton-Thomas JR; Shuman MA; Rosenberg S
    Cancer Res; 1996 May; 56(10):2428-33. PubMed ID: 8625323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
    Olaso E; Salado C; Egilegor E; Gutierrez V; Santisteban A; Sancho-Bru P; Friedman SL; Vidal-Vanaclocha F
    Hepatology; 2003 Mar; 37(3):674-85. PubMed ID: 12601365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell.
    Yao Z; Che XC; Lu R; Zheng MN; Zhu ZF; Li JP; Jian X; Shi LX; Liu JY; Gao WY
    Mol Med; 2007; 13(1-2):14-21. PubMed ID: 17515953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma.
    Yi C; Huang Y; Guo ZY; Wang SR
    Acta Pharmacol Sin; 2005 May; 26(5):629-34. PubMed ID: 15842785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.
    Maciag PC; Seavey MM; Pan ZK; Ferrone S; Paterson Y
    Cancer Res; 2008 Oct; 68(19):8066-75. PubMed ID: 18829565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
    Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
    Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK; Halsør EF
    Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered angiogenesis underlying age-dependent changes in tumor growth.
    Pili R; Guo Y; Chang J; Nakanishi H; Martin GR; Passaniti A
    J Natl Cancer Inst; 1994 Sep; 86(17):1303-14. PubMed ID: 7520508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.
    Struyf S; Burdick MD; Peeters E; Van den Broeck K; Dillen C; Proost P; Van Damme J; Strieter RM
    Cancer Res; 2007 Jun; 67(12):5940-8. PubMed ID: 17575164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells.
    Dkhissi F; Lu H; Soria C; Opolon P; Griscelli F; Liu H; Khattar P; Mishal Z; Perricaudet M; Li H
    Hum Gene Ther; 2003 Jul; 14(10):997-1008. PubMed ID: 12869217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells.
    Kikuchi T; Crystal RG
    Hum Gene Ther; 1999 May; 10(8):1375-87. PubMed ID: 10365667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
    Humphries MJ; Yamada KM; Olden K
    J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis.
    Watanabe M; McCormick KL; Volker K; Ortaldo JR; Wigginton JM; Brunda MJ; Wiltrout RH; Fogler WE
    Am J Pathol; 1997 May; 150(5):1869-80. PubMed ID: 9137109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice.
    Was H; Cichon T; Smolarczyk R; Rudnicka D; Stopa M; Chevalier C; Leger JJ; Lackowska B; Grochot A; Bojkowska K; Ratajska A; Kieda C; Szala S; Dulak J; Jozkowicz A
    Am J Pathol; 2006 Dec; 169(6):2181-98. PubMed ID: 17148680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.